DK2524227T3 - Forudsigelse af allergiske reaktioner - Google Patents
Forudsigelse af allergiske reaktionerInfo
- Publication number
- DK2524227T3 DK2524227T3 DK11796780.2T DK11796780T DK2524227T3 DK 2524227 T3 DK2524227 T3 DK 2524227T3 DK 11796780 T DK11796780 T DK 11796780T DK 2524227 T3 DK2524227 T3 DK 2524227T3
- Authority
- DK
- Denmark
- Prior art keywords
- prevention
- allergic reactions
- allergic
- reactions
- Prior art date
Links
- 206010020751 Hypersensitivity Diseases 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5026—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on cell morphology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
- G01N33/505—Cells of the immune system involving T-cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
- G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Physiology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1020004.6A GB2485816A (en) | 2010-11-25 | 2010-11-25 | In vitro model for the prediction of immunogenicity, hypersensitivity or allergenicity |
| PCT/GB2011/052312 WO2012069838A1 (en) | 2010-11-25 | 2011-11-24 | Predicting allergic reactions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2524227T3 true DK2524227T3 (da) | 2014-04-28 |
Family
ID=43500629
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK11796780.2T DK2524227T3 (da) | 2010-11-25 | 2011-11-24 | Forudsigelse af allergiske reaktioner |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US9651544B2 (da) |
| EP (1) | EP2524227B1 (da) |
| DK (1) | DK2524227T3 (da) |
| ES (1) | ES2455598T3 (da) |
| GB (1) | GB2485816A (da) |
| WO (1) | WO2012069838A1 (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2485816A (en) | 2010-11-25 | 2012-05-30 | Alcyomics Ltd | In vitro model for the prediction of immunogenicity, hypersensitivity or allergenicity |
| GB201303485D0 (en) * | 2013-02-27 | 2013-04-10 | Alcyomics Ltd | Skin model |
| WO2020102721A1 (en) * | 2018-11-16 | 2020-05-22 | Rapa Therapeutics, Llc | Immune monitoring of neuro-inflammatory amyotrophic lateral sclerosis (als) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2847268B1 (fr) * | 2002-11-19 | 2006-09-29 | Coletica | Procede d'identification d'une modification eventuelle d'au moins un parametre biologique mettant en oeuvre des cellules vivantes soumises a un stress et des cellules vivantes non soumises a ce meme stress |
| DE102004061289B4 (de) * | 2004-12-20 | 2009-04-02 | Euroderm Gmbh | Testkit mit Testzellen und Immunzellen sowie Herstellverfahren hierfür |
| WO2007031273A2 (en) * | 2005-09-16 | 2007-03-22 | Universität Bern | Artificial immune-reconstituted epidermis equivalents |
| WO2008051660A2 (en) * | 2006-09-12 | 2008-05-02 | Entelos, Inc. | Apparatus and method for computer modeling chemical sensitivity of skin |
| CN101939644B (zh) * | 2008-01-10 | 2014-06-11 | 休雷尔公司 | 免疫系统模拟装置和方法 |
| ATE509095T1 (de) * | 2008-05-28 | 2011-05-15 | Symrise Ag | Menschliches ex-vivo-hautmodell |
| CA2736485C (en) * | 2008-09-10 | 2018-04-24 | Rules-Based Medicine, Inc. | Cell culture system for determining the sensitizing, allergenic and/or irritating effect of a substance |
| GB2485816A (en) * | 2010-11-25 | 2012-05-30 | Alcyomics Ltd | In vitro model for the prediction of immunogenicity, hypersensitivity or allergenicity |
-
2010
- 2010-11-25 GB GB1020004.6A patent/GB2485816A/en not_active Withdrawn
-
2011
- 2011-11-24 US US13/989,581 patent/US9651544B2/en active Active
- 2011-11-24 WO PCT/GB2011/052312 patent/WO2012069838A1/en active Application Filing
- 2011-11-24 DK DK11796780.2T patent/DK2524227T3/da active
- 2011-11-24 EP EP11796780.2A patent/EP2524227B1/en active Active
- 2011-11-24 ES ES11796780.2T patent/ES2455598T3/es active Active
-
2017
- 2017-04-10 US US15/484,024 patent/US10073084B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| GB2485816A (en) | 2012-05-30 |
| WO2012069838A1 (en) | 2012-05-31 |
| GB201020004D0 (en) | 2011-01-12 |
| ES2455598T3 (es) | 2014-04-16 |
| US20170285001A1 (en) | 2017-10-05 |
| US10073084B2 (en) | 2018-09-11 |
| EP2524227A1 (en) | 2012-11-21 |
| EP2524227B1 (en) | 2014-01-22 |
| US20130244244A1 (en) | 2013-09-19 |
| US9651544B2 (en) | 2017-05-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2567524T3 (da) | Reduktion af protokolspild | |
| DK2603232T3 (da) | Stabile formuleringer af linaclotid | |
| DK2528602T4 (da) | Formuleringer af bendamustin | |
| CU24126B1 (es) | Compuestos y composiciones de tioacetato | |
| DK2558105T3 (da) | Bardoxolonmethyl til behandling af fedme | |
| DK2555704T3 (da) | Visning af hæmostatiske parametre | |
| DK2521750T3 (da) | Hærdning af væsker | |
| DK2526425T3 (da) | Fremgangsmåde til diagnosticering af endometriel receptivitet | |
| DK2633006T3 (da) | Fremstilling af fornybart bio-destillat | |
| CO6980141A1 (es) | Compuestos y composiciones de poliglicerilo catónicos | |
| DK2733803T4 (da) | Sektion af kabelbakke | |
| BR112014003878A2 (pt) | síntese de r-bifenilalaninol | |
| DK2822568T3 (da) | Anvendelser af caseinsammensætninger | |
| DK2800572T3 (da) | Sammensætning af ellagitannin-rige ekstrakter | |
| DK2453858T3 (da) | Fremgangsmåde | |
| DK2571843T3 (da) | Forbedret fremstilling af chalcon-derivater | |
| DK2632475T3 (da) | Sammensætninger til behandling af perifere sår af forskellig oprindelse | |
| DK2501381T3 (da) | Behandling af atrieflimmer | |
| BR112012021749A2 (pt) | processos e compostos | |
| DK2838850T3 (da) | Oprensning af titantetrachlorid | |
| DK2407155T3 (da) | Formuleringer af inecalcitol | |
| DK2524227T3 (da) | Forudsigelse af allergiske reaktioner | |
| FR2955473B1 (fr) | Structure de presentoir | |
| DK2780003T3 (da) | Behandling af binyrebarkinsufficiens | |
| FR2956419B1 (fr) | Elements de construction calorifuges |